Why the study?
Limited studies exist regarding the effect of treatment innovations, time of admission, and work mode on mortality in patients presenting with STEMI.
Does treatment at on-call vs on-duty centers or weekend vs weekday admission affect 1-year mortality in STEMI patients?
Does treatment at on-call vs on-duty centers or weekend vs weekday admission affect 1-year mortality in STEMI patients?
Answers are grounded in this paper and cite their sources.
Work mode (on-call vs on-duty) and time of admission (weekend vs weekday) do not significantly affect 1-year mortality in STEMI patients treated at PCI-capable clinics.
Treatment of acute myocardial infarction has evolved steadily. However, limited studies exist regarding the effect of all innovations on mortality. We aimed to investigate the effect of time of admission and work mode on 1-year outcomes in patients presenting with ST-segment elevation myocardial infarction (STEMI). Based on the TURKMI registry, we analyzed 735 STEMI patients recruited consecutively and prospectively from 50 PCI-capable cardiology clinics within a prespecified two-week period. Centers were categorized as “on-call” and “on-duty” according to their work mode. At 1-year follow-up, all-cause mortality and cardiovascular mortality were the primary outcomes. The secondary outcome was a composite of coronary revascularization, re-infarction/stroke, and recurrent angina. One-fifth of the participants (19.5%) were treated in the on-call group. All-cause mortality (7.9 vs 10.5%, aHR: 1.16, P = .650) and cardiovascular mortality rates (6.1 vs 9.1%, aHR: 1.35, P = .413) were similar between centers’ modes of work. Likewise, both groups were equally likely to undergo coronary revascularization ( P = .278), re-MI/stroke ( P = .280), recurrent angina ( P = .175), and the composite outcome of these components ( P = .482). No significant difference was observed in primary outcomes between weekend and weekday admissions. In conclusion, we observed similar outcomes between the on-call and on-duty groups among STEMI patients.
No takes yet. Share an insight, caveat, or question.
Genç et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: